Original Research
Accepted on 29 Aug 2025
FBXO2 promotes hepatocellular carcinoma progression and sorafenib resistance by targeting USP49 for proteasomal degradation
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 29 Aug 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 29 Aug 2025
in Public Health Policy
Systematic Review
Accepted on 29 Aug 2025
in AI in Finance
Original Research
Accepted on 29 Aug 2025
in Public Health Education and Promotion
Original Research
Accepted on 29 Aug 2025
in Microorganisms in Vertebrate Digestive Systems
Original Research
Accepted on 29 Aug 2025
in Pituitary Endocrinology
Original Research
Accepted on 29 Aug 2025
in Thyroid Endocrinology
Original Research
Accepted on 29 Aug 2025
in Microorganisms in Vertebrate Digestive Systems
Systematic Review
Accepted on 29 Aug 2025
in Children and Health
Systematic Review
Accepted on 29 Aug 2025
in Children and Health
Review
Accepted on 29 Aug 2025
in Microorganisms in Vertebrate Digestive Systems
Original Research
Accepted on 29 Aug 2025
in Thyroid Endocrinology
Original Research
Accepted on 29 Aug 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 29 Aug 2025
in Health Psychology
Original Research
Accepted on 29 Aug 2025
in Thyroid Endocrinology
Original Research
Accepted on 29 Aug 2025
in Occupational Health and Safety